MDT

86.08

+0.56%↑

A

121.65

+2.99%↑

VEEV

167.9

+0.35%↑

HQY

85.93

+1.81%↑

NEOG

9.5

+2.81%↑

MDT

86.08

+0.56%↑

A

121.65

+2.99%↑

VEEV

167.9

+0.35%↑

HQY

85.93

+1.81%↑

NEOG

9.5

+2.81%↑

MDT

86.08

+0.56%↑

A

121.65

+2.99%↑

VEEV

167.9

+0.35%↑

HQY

85.93

+1.81%↑

NEOG

9.5

+2.81%↑

MDT

86.08

+0.56%↑

A

121.65

+2.99%↑

VEEV

167.9

+0.35%↑

HQY

85.93

+1.81%↑

NEOG

9.5

+2.81%↑

MDT

86.08

+0.56%↑

A

121.65

+2.99%↑

VEEV

167.9

+0.35%↑

HQY

85.93

+1.81%↑

NEOG

9.5

+2.81%↑

Search

Quanterix Corp

Închisă

SectorSănătate

3.52 4.14

Rezumat

Modificarea prețului

24h

Curent

Minim

3.36

Maxim

3.7

Indicatori cheie

By Trading Economics

Venit

10M

-23M

Vânzări

3.7M

44M

Marjă de profit

-52.712

Angajați

450

EBITDA

15M

-17M

Recomandări

By TipRanks

Recomandări

Neutru

Prognoză pe 12 luni

+120.59% upside

Dividende

By Dow Jones

Următoarele câștiguri

11 mai 2026

Statistici piață

By TradingEconomics

Capitalizare de piață

-137M

159M

Deschiderea anterioară

-0.62

Închiderea anterioară

3.52

Sentimentul știrilor

By Acuity

50%

50%

168 / 348 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Neutral Evidence

Quanterix Corp Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

17 apr. 2026, 20:26 UTC

Achiziții, Fuziuni, Preluări

UCB to Buy Neurona Therapeutics for Up to $1.15 Billion

17 apr. 2026, 18:15 UTC

Evenimente importante

Fed's Waller: Prolonged Iran Conflict Could Block Path to Rate Cuts

17 apr. 2026, 16:49 UTC

Evenimente importante

Week Ahead for FX, Bonds: U.S. Retail Sales, PMI -2-

17 apr. 2026, 16:49 UTC

Evenimente importante

Week Ahead for FX, Bonds: U.S. Retail Sales, PMI Data Due as Focus Remains on Middle East

17 apr. 2026, 22:58 UTC

Câștiguri

Grupo Aeroportuario Del Pacifico: Announces Filing of 2025 Annual Report and Form 20-F

17 apr. 2026, 21:32 UTC

Market Talk

Cerebras IPO Adds to Big Year For AI Firms Going Public -- Market Talk

17 apr. 2026, 21:22 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

17 apr. 2026, 21:22 UTC

Market Talk

Moody's Downgrades Belgium to A1 -- Market Talk

17 apr. 2026, 20:52 UTC

Câștiguri

Schwab Investors Get Spooked by JPMorgan's AI Strategy. The Big Worry Is Cash Sweeps. -- Barrons.com

17 apr. 2026, 20:50 UTC

Market Talk
Câștiguri
Achiziții, Fuziuni, Preluări

Tech, Media & Telecom Roundup: Market Talk

17 apr. 2026, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

17 apr. 2026, 20:29 UTC

Câștiguri

These Stocks Are Today's Movers: Royal Caribbean, Dow Inc., Netflix, Intel, Albemarle, Autoliv, Alcoa, and More -- Barrons.com

17 apr. 2026, 20:11 UTC

Achiziții, Fuziuni, Preluări

UCB to Buy Neurona Therapeutics for Up to $1.15B

17 apr. 2026, 19:34 UTC

Market Talk
Câștiguri
Achiziții, Fuziuni, Preluări

Global Equities Roundup: Market Talk

17 apr. 2026, 19:34 UTC

Market Talk
Câștiguri
Achiziții, Fuziuni, Preluări

Analysts See Netflix's Deal Commentary as Notable -- Market Talk

17 apr. 2026, 19:31 UTC

Market Talk
Evenimente importante

Oil Futures Fall on Reopening of Strait of Hormuz -- Market Talk

17 apr. 2026, 19:26 UTC

Market Talk

U.S. Natural Gas Futures Edge Up -- Market Talk

17 apr. 2026, 19:21 UTC

Market Talk

Albemarle's Outperformance Belies Longer-Term Risks -- Market Talk

17 apr. 2026, 19:15 UTC

Market Talk

Danaher Seen Rebounding in 2H After Tools-Sector Weakness -- Market Talk

17 apr. 2026, 19:07 UTC

Market Talk

Danaher Faces Tough Comparative but Long‑Term Story Intact -- Market Talk

17 apr. 2026, 18:57 UTC

Evenimente importante

U.S. Stocks Surge on Hope Iran War Nearing End. Foreign Leaders Have a More Sober View. -- Barrons.com

17 apr. 2026, 18:53 UTC

Achiziții, Fuziuni, Preluări

UCB Expects 2026 Adjusted Ebitda Growth in High Single-Digit to Mid-Teens Percentage Range at Constant Exchange Rates

17 apr. 2026, 18:53 UTC

Achiziții, Fuziuni, Preluări

UCB 2026 Rev Guidance Unchanged

17 apr. 2026, 18:52 UTC

Achiziții, Fuziuni, Preluări

UCB: Neurona Deal to Include $650M Upfront and Up to $500M in Potential Future Milestones

17 apr. 2026, 18:52 UTC

Achiziții, Fuziuni, Preluări

UCB to Acquire Neurona Therapeutics for Up to $1.15B Including Potential Milestones

17 apr. 2026, 18:14 UTC

Market Talk
Evenimente importante

Precious Metals Close Higher as Stronger Demand Eyed -- Market Talk

17 apr. 2026, 18:00 UTC

Evenimente importante

Fed's Waller: Quick Resolution in Middle East Could Allow Cuts Later This Year

17 apr. 2026, 18:00 UTC

Evenimente importante

Fed's Waller: Job Losses May Not Signal Recession Amid Demographic Changes

17 apr. 2026, 17:31 UTC

Market Talk
Evenimente importante

U.S. Oil Rig Count Down By 1 at 410 -- Market Talk

17 apr. 2026, 17:26 UTC

Market Talk
Câștiguri

Netflix's Ability to Grow Engagement Seen as Up in the Air -- Market Talk

Comparație

Modificare preț

Quanterix Corp Așteptări

Obiectiv de preț

By TipRanks

120.59% sus

Prognoză pe 12 luni

Medie 7.5 USD  120.59%

Maxim 8 USD

Minim 7 USD

În baza a 2 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruQuanterix Corp - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Neutru

2 ratings

0

Cumpărare

2

Păstrare

0

Vânzare

Scor tehnic

By Trading Central

5.34 / 6.015Suport & Rezistență

Termen scurt

Neutral Evidence

Termen mediu

Bullish Evidence

Termen lung

No Evidence

Sentiment

By Acuity

168 / 348 Clasament în Sănătate

Sentimentul știrilor

Neutral

Volatilitate

Sub medie

Volumul știrilor (RCV)

Peste medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Quanterix Corp

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications. It also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include assays include all components required to run enzyme-based immunoassay, such as beads, capture and detector reagents, and enzyme reagents and substrate; and replacement parts, reagents, and antibodies. In addition, it offers contract research services, including sample testing, homebrew assay development, custom assay development, lucent diagnostic, and LDT testing services. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. It sells its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct field sale, support organizations, and distributors or sales agents. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.
help-icon Live chat